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Article

Unique and redundant functions of NKp46+
ILC3s in models of intestinal inflammation
Christina Song,1 Jacob S. Lee,1 Susan Gilfillan,1 Michelle L. Robinette,1
Rodney D. Newberry,2 Thaddeus S. Stappenbeck,1 Matthias Mack,3
Marina Cella,1 and Marco Colonna1
of Pathology and Immunology and 2Department of Medicine, Washington University School of Medicine,
St. Louis, MO 63110
3Department of Nephrology, University Hospital Regensburg, 93042 Regensburg, Germany

Group 3 ILCs (ILC3s) are innate sources of IL-22 and IL-17 and include lymphoid tissueinducer (LTi)-like and NKp46+ subsets. Both depend on RORt and aryl hydrocarbon
receptor, but NKp46+ILC3s also require Notch and T-bet for their development and are
transcriptionally distinct. The extent to which these subsets have unique functions, especially in the context of T cell– and B cell–sufficient mice, remains largely unclear. To
investigate the specific function of NKp46+ILC3s among other ILC3 subsets and T cells, we
generated mice selectively lacking NKp46+ILC3s or all ILC3s and crossed them to T cell–
deficient mice, thus maintaining B cells in all mice. In mice lacking T cells, NKp46+ILC3s
were sufficient to promote inflammatory monocyte accumulation in the anti-CD40 innate
colitis model through marked production of GM-CSF. In T cell–competent mice, lack of
NKp46+ILCs had no impact on control of intestinal C. rodentium infection, whereas lack of
all ILC3s partially impaired bacterial control. Thus, NKp46+ILC3s have a unique capacity to
promote inflammation through GM-CSF–induced accumulation of inflammatory monocytes,
but are superseded by LTi-like ILC3s and T cells in controlling intestinal bacterial infection.
CORRESPONDENCE
Marco Colonna:
mcolonna@pathology.wustl.edu
OR
Marina Cella:
mcella@pathology.wustl.edu
Abbreviations used: AHR, aryl
hydrocarbon receptor; GMCSF, granulocyte macrophagecolony stimulating factor;
GMP, granulocyte-monocyte
progenitor; ILC, innate lymphoid cell; LTi, lymphoid
tissue-inducer; TSLP, thymic
stromal lymphopoietin.

Innate lymphoid cells (ILCs) are a heterogeneous population of lymphocytes that lack
antigen-specific receptors and respond to changes
in the tissue cytokine microenvironment by secreting effector cytokines (Rankin et al., 2013a;
Diefenbach et al., 2014; Artis and Spits, 2015;
Eberl et al., 2015). Based on the cytokines secreted
and transcription factors required for their development, ILCs are divided into three major
groups: ILC1s produce IFN- in response to
IL-12, IL-15, and IL-18 and depend on T-bet
for development; ILC2s secrete IL-5 and IL-13
in response to IL-25, IL-33, and thymic stromal
lymphopoietin (TSLP) and require GATA3,
ROR, and Bcl11b; ILC3s produce IL-22,
IL-17, and granulocyte macrophage-colony stimulating factor (GM-CSF) when stimulated with
IL-23 and/or IL-1 and require RORt and
aryl hydrocarbon receptor (AHR). These major
ILC groups are heterogeneous and include distinct subsets that more subtly differ in phenotype, transcriptional profile, tissue distribution,
J.S. Lee’s present address is Merck Research Laboratories,
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and developmental requirements (Robinette
et al., 2015).
ILC3s have been associated with many immune responses in the gastrointestinal tract.They
provide defense against intestinal infections by
various pathogenic bacteria, such as Citrobacter
rodentium (C. rodentium). This protective effect is
chiefly mediated by secretion of IL-22, which
prompts epithelial cells to produce antimicrobial
peptides that kill bacteria (Zheng et al., 2008;
Tumanov et al., 2011; Guo et al., 2014), as well as
fucosylated proteins that are shed in the intestinal lumen and modify bacterial metabolism,
thereby attenuating bacterial virulence (Pickard
et al., 2014). ILC3s also promote intestinal homeostasis in the steady state through multiple
mechanisms. These include containing intestinal
microbiota through IL-22 secretion (Sonnenberg
et al., 2012), inducing T cell tolerance to bacterial
antigens through MHC class II presentation
(Hepworth et al., 2013; Hepworth et al., 2015),
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ILC3s in vivo. To overcome this problem, we generated
conditional knock-out mice in which AHR or RORt
deficiency is restricted to RORt- and NKp46-expressing
cells, respectively, obtaining mice that lack all ILC3 subsets or
only NKp46+ILC3s. Moreover, these strains were crossed to
a strain that lacks  and  T cells to evaluate ILC3 functions in B cell–sufficient mice in the presence or absence
of T cells.
We examined these mouse lines in two models of intestinal inflammation, including a commonly used model of
colitis and an infection model. The anti-CD40 model of
colitis induces pathology caused by hyperactivation of innate
immunity, but can only be used in immunocompromised
mice (Uhlig et al., 2006). In this model, we found that ILC3s
elicited robust inflammation and accumulation of pathogenic
Ly6C+ inflammatory monocytes that were dependent on
excessive production of GM-CSF and IL-22. Moreover,
NKp46+ILC3s were sufficient to induce inflammation in this
model, demonstrating a nonredundant inflammatory function that was partially caused by their enhanced capacity to
secrete GM-CSF in vivo. We also examined ILC3-deficient
mouse lines in host defense against C. rodentium. ILC3s were
essential in T cell–deficient mice but partially redundant in
T cell–competent mice. However, the NKp46+ILC3 subset
was always redundant, both in T cell–competent and T cell–
deficient mice. In conclusion, NKp46+ILC3s have a unique
role in GM-CSF–mediated recruitment and activation of inflammatory monocytes during innate intestinal inflammation,
but are redundant for clearance of C. rodentium, whether T cells
are present or absent.
RESULTS
Generation of mice that lack all ILC3s and NKp46+ILC3s
We identified ILC3s in mouse intestine as CD45+Lin–
Thy1+RORt+ cells. As previously shown (Vonarbourg et al.,
2010), ILC3s were generally more abundant in the small intestine than in cecum and colon (Fig. S1 A). Based on NKp46
expression, ILC3s were distinguished into NKp46+ILC3s and
LTi-like ILC3s (NKp46–) subsets. LTi-like ILC3s subsets were
further divided in CCR6+ and CCR6– subsets (Fig. S1 A and
not depicted; Diefenbach et al., 2014; Eberl et al., 2015).
To engineer mice with specific deletions of ILC3s, we crossed
Ahrf/f mice to Rorc(t)-cre mice (AR mice) and Rorc(t)f/f mice
to NKp46-cre mice (RN mice). AR mice had a marked reduction of all ILC3s (Fig. S1 B). Moreover, because RORt
is transiently expressed during thymic lymphocyte development, AR mice also lacked AHR in T cells (unpublished data),
which may affect some functions of TH17 and TH22 cells,
including IL-22 secretion, in vitro but not in vivo (Martin et al.,
2009; Duarte et al., 2013; Qiu et al., 2013; unpublished data).
RN mice selectively lack NKp46+ILC3s (which also include
ex-RORt+ ILC3s; Fig. S1 B) and, therefore, are suitable to
study the functions of NKp46+ILC3s in otherwise immunocompetent mice. AR and RN mice were then crossed with
Tcrb/Tcrd/ (Tcrbd/) mice to obtain mice that lack ILC3s
and T cells (ART mice; Fig. S1, C and D), or NKp46+ILC3s
NKp46+ ILC3s in intestinal inflammation | Song et al.
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and sustaining the tolerogenic function of intestinal DCs
through GM-CSF secretion (Mortha et al., 2014). Furthermore, ILC3s control T cell–dependent and –independent IgA
production through lymphotoxins (Kruglov et al., 2013), as
well as marginal zone B cell Ig production (Magri et al., 2014).
ILC3s can also protect intestinal stem cells from immunemediated tissue damage in graft versus host disease (Dudakov
et al., 2015). In some cases, ILC3s have deleterious roles. For
example, ILC3s have been implicated in Helicobacter hepaticus–
driven innate colitis, which is associated with an increased
production of IL-17 and IFN- in the colon (Buonocore
et al., 2010). Inappropriate activation of ILC3s has also been
shown to induce intestinal damage through excessive IL-22–
induced production of neutrophil chemoattractants by epithelial cells, resulting in accumulation of neutrophils and
tissue destruction (Eken et al., 2014).
In mice, ILC3s include two major subsets (Diefenbach
et al., 2014; Eberl et al., 2015). Lymphoid tissue-inducer (LTi)like ILC3s have phenotypic features overlapping with those of
fetal LTi cells that promote lymphoid organogenesis, including
lack of lineage markers along with expression of CD127 and
lymphotoxins. Some cells within this subset express the chemokine receptor CCR6 and are thought to have a distinct
progenitor from CCR6– LTi-like ILC3s (Vonarbourg et al.,
2010; Constantinides et al., 2014; Klose et al., 2014). However,
both CCR6+ and CCR6– ILC3s require RORt and AHR
for development. NKp46+ILC3s express the NK cell marker
NKp46 in addition to CD127 and require AHR (Kiss et al.,
2011; Lee et al., 2012; Qiu et al., 2012), Notch (Lee et al., 2012)
and T-bet for development (Sciumé et al., 2012; Klose et al.,
2013; Rankin et al., 2013b). Under certain inflammatory conditions, NKp46+ILC3s down-regulate expression of RORt,
increase T-bet expression and become a source of IFN-
(Vonarbourg et al., 2010). These cells, known as ex-RORt
ILC3s, may contribute to host-defense against certain bacterial
infections, such as Salmonella thyphymurium (Klose et al., 2013).
LTi-like and NKp46+ILC3s also differ in their distribution
within the intestine; LTi-like ILC3s are found throughout the
intestine in association with lymphoid follicles; NKp46+ILC3s
are diffuse in the lamina propria and their distribution is dependent on the expression of the chemokine receptor CXCR6
(Satoh-Takayama et al., 2014). Notably, LTi-like ILC3s and
NKp46+ ILC3s share expression of some core genes compared
with other ILCs, such as IL-22, but are also transcriptionally
distinct (Reynders et al., 2011; Robinette et al., 2015).
To date, it is unclear whether NKp46+ and LTi-like ILC3
subsets are redundant or have specialized functions. Moreover,
the functions of NKp46+ and LTi-like ILC3s have been frequently examined in immunodeficient mice that lack adaptive responses. To address these gaps in our understanding of
ILC biology, we examined novel mouse lines that lack ILC3s.
RORt- and AHR-deficient mice lack ILC3s and have been
used as ILC3-deficient models. These transcription factors,
however, function in a variety of cells types, including other
lymphocytes and nonhematopoietic populations, making
it difficult to unambiguously assess the specific functions of
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and T cells (RNT mice; Fig. S1 C and S1 D). Thus, AR, RN,
ART and RNT mice can be used to parse unique and redundant functions of ILC3s and T cells, while preserving B cells
in all mice.

Lack of ILC3s curtails intestinal accumulation of Ly6C+
monocytes and neutrophils
Upon induction of anti-CD40–mediated colitis, CD11b+Ly6G+
neutrophils and CD11b+Ly6G–Ly6C+ monocytes accumulated in the intestines of Tcrbd/ mice, peaked at day 4 in the
small intestine and sustained up to day 7 in the colon (Fig. 2 A).
ART mice had fewer intestinal neutrophils and inflammatory monocytes than did Tcrbd/ mice (Fig. 2 B and not
JEM Vol. 212, No. 11

Adoptive transfer of intestinal ILC3s into lymphopenic mice
is sufficient to enable innate immune colitis
To corroborate the proinflammatory function of ILC3s in
anti-CD40 colitis we performed adoptive transfer experiments. We isolated ILC3s from the small intestine of Rag1/
mice (unpublished data), transferred them into NOD/SCID
x c/ (NSG) mice, and waited 2 or 8 wk to allow cells to
repopulate the intestine. Next, we induced colitis by injection
of anti-CD40 and examined weight loss and intestinal pathology after 1 wk. NSG mice reconstituted with ILC3s for
8 wk quickly lost weight and remained underweight for the
duration of the experiment (Fig. 3 A). In these mice, ILC3s
reconstituted the intestine, whereas no ILC3s were detected
in the spleen (Fig. 3 B).Weight loss was paralleled by a significant recruitment of neutrophils and inflammatory monocytes
(Fig. 3, C and D). In contrast, NSG mice that had not been
reconstituted or were reconstituted only for 2 wk before colitis induction showed no weight loss, absence of ILC3s in the
intestine or spleen, and no intestinal recruitment of neutrophils or monocytes (unpublished data). These results conclusively demonstrate a proinflammatory function for ILC3s
in anti-CD40–induced colitis.
Depletion of inflammatory monocytes protects mice from
anti-CD40–induced colitis
Our data suggested that ILC3s promote intestinal inflammation by inducing recruitment and activation of both neutrophils and inflammatory monocytes, which may work in
concert to drive inflammation and tissue damage. To test this
1871
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Lack of ILC3s curbs intestinal inflammation
in anti–CD40-induced colitis
To explore the role of ILC3s in intestinal inflammation, we
used a model of colitis induced by injection of anti-CD40
into mice that lack adaptive immunity, such as Rag1-deficient
mice (Uhlig et al., 2006). In this model, anti-CD40 causes inappropriate and unrestricted activation of myeloid cells, leading to massive release of inflammatory cytokines. Colitis and
mucosal immunopathology depend on IL-23, whereas IL-12
promotes wasting disease and elevation of serum inflammatory mediators. Although the anti-CD40 model is usually
performed in Rag-deficient mice that lack both T and B cells,
we chose to examine the role of ILC3 in Tcrbd/ mice,
which lack T cells but are B cell competent. After anti-CD40
injection, Tcrbd/ mice quickly lost body weight and remained
severely underweight for the duration of the experiment (7 d;
Fig. 1 A). In contrast, ART mice lost less weight and quickly
recovered, beginning at day 4. At day 7 after treatment, less
pronounced colonic shortening and milder histopathology
was evident in ART mice than in Tcrbd/ mice (Fig. 1,
B and C), whereas there was no difference between Tcrbd/
and ART naive animals (unpublished data).
A marked increase in IL-22, the inflammatory mediator
S100A8, the enzyme NOS2 that produces nitric oxide,
as well as many inflammatory cytokines, such as IL-17a/f,
IFN-, TNF, IL-1, IL-23p19, IL-12p40, and IL-6, was
obvious in the intestines of Tcrbd/ mice injected with
anti-CD40 (Fig. 1, D and E). Notably, IL-12p35 expression
was not elevated, indicating a more predominant pathogenic role for IL-23 than for IL-12 in intestinal inflammation. Chemoattractants and growth factors for neutrophils
and inflammatory monocytes, such as CXCL1, CCL2, G-CSF,
and GM-CSF, were also increased. The induction in inflammatory mediators was paralleled by an increase of
IL-10, which may reflect the activation of feedback mechanisms for reducing inflammation. Lower amounts of all
these cytokines and chemokines were detected in the intestines of ART mice in comparison with the Tcrbd/ mice
(Fig. 1, D and E).We conclude that ART mice exhibit significantly less clinical, pathological, and biochemical features of
intestinal inflammation than do Tcrbd/ mice after administration of anti-CD40.

depicted), whereas there was no difference between neutrophils and inflammatory monocytes in untreated mice (unpublished data). Intestinal CD11c+ DCs (including CD11b+
and CD11b– subsets) and CD11c–CD11b+ macrophages were
found at similar frequencies in the colons of Tcrbd/ and
ART mice, both before and after anti-CD40 (Fig. 2 B and
not depicted).
We also assessed the capacity of intestinal myeloid cells to
produce inflammatory cytokines. In Tcrbd/ mice injected
with anti-CD40, both neutrophils and inflammatory monocytes produced IL-1 and TNF at day 7 p.i.; inflammatory
monocytes also produced IL-6 (unpublished data). DC and
resident macrophages produced small amounts of these cytokines. A marked reduction in cytokine production by inflammatory monocytes, but not neutrophils, was noted in ART
mice (unpublished data). These data indicate that lack of
ILC3s results in accumulation of fewer neutrophils and inflammatory monocytes, which is consistent with the reduced
intestinal content of CXCL1, CCL2, GM-CSF, and G-CSF
observed in ART mice (Fig. 1, D and E). Moreover, lack of
ILC3s selectively diminishes cytokine secretion by inflammatory monocytes, most likely due to reduced availability of
GM-CSF (Fig. 1 D), which has been shown to promote
monocytic functions (Griseri et al., 2012). We conclude that
ILC3s have an important function in recruiting and activating
Ly6C+ inflammatory monocytes in the absence of T cells.
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Figure 1. ILC3 deficiency protects mice from anti-CD40–induced colitis. ART and Tcrbd/ mice were injected with anti-CD40. (A) Mice were
weighed daily, from day 0 to 7 p.i. (B) Colons were harvested and overall lengths measured 7 d p.i. Colon lengths were also assessed in Ahrf/f x Tcrbd/
(flox control mice) and Rort-cre x Tcrbd/ (Cre control mice; not depicted). A and B represent five independent experiments with 4–10 mice/group per
experiment. (C) Colons were stained with hematoxylin and eosin and scored for severity of colitis on day 7, where a higher score corresponds to increased
pathology. Data represent two independent experiments with four to five mice/group. (D) mRNA expression of inflammatory mediators. Colons were collected from ART and Tcrbd/ mice at day 4 and 7 after anti-CD40 injection and the indicated transcripts were measured via quantitative RT-PCR. All
gene expression values were normalized to Gapdh. (E) Protein expression of inflammatory mediators. Colonic lamina propria was processed at day 7 after
anti-CD40 treatment; 106 cells were isolated and cultured for 4 h. The indicated cytokines were measured by cytometric bead array of the culture supernatants. (D and E) Data represent two independent experiments with five mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, Student’s
t test. Bars represent mean ± SEM.
1872
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hypothesis, we attempted to deplete both cell types by using
an anti-Ly6G/Ly6C (GR1) antibody (Daley et al., 2008).
We found that administration of the antibody had no protective effect, as disease severity was unchanged compared with
control treatment (Fig. 4 A). However, a close examination
of the depleting efficacy of anti-GR1 administration revealed that this antibody successfully depleted both neutrophils and inflammatory monocytes in blood and spleen
(not depicted), whereas only neutrophils were effectively depleted in the intestine (Fig. 4 A). Inflammatory monocytes
persisted in the intestine even after 5 d of daily injections of
JEM Vol. 212, No. 11

the antibody. These results suggested that neutrophils are
not critical in inducing intestinal inflammation during antiCD40–induced colitis, but instead, that inflammatory monocytes may be important.
To test this hypothesis, we tried to selectively deplete inflammatory monocytes using an antibody for CCR2 (MC21), which is a selective marker of these cells (Shi and Pamer,
2011). Anti-CCR2–treated mice had less severe disease, lost
less body weight, and recovered faster than did mice treated
with a control antibody (Fig. 4 B). As expected, anti-CCR2
treatment resulted in significantly lower numbers of intestinal
1873
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Figure 2. Evaluation of intestinal myeloid populations in ART and Tcrbd/ mice treated with anti-CD40. (A) Tcrbd/ mice were treated with
anti-CD40 and sacrificed at days 0, 4, and 7. Cells were purified from colonic and small intestinal lamina propria. Ly6G+ neutrophils and Ly6G–Ly6Chi inflammatory monocytes were distinguished within the population of live CD45+CD19–CD11b+ cells. Representative plots (top) and neutrophil and monocyte numbers among 106 total leukocytes (bottom) are indicated. Data represent three independent experiments with two mice/time point. (B) Colonic
lamina propria cells from Tcrbd/ and ART mice were collected at day 7 after anti-CD40 treatment. Live, CD45+CD19– cells were analyzed for expression
of Ly6G, Ly6C, CD11c, and CD11b. Data represent five independent experiments with two mice/group. Representative plots (top) and total numbers of
neutrophils, monocytes, and DCs among 106 total leukocytes (bottom) are indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001, student’s t test. Bars represent
mean ± SEM.

Published October 12, 2015

inflammatory monocytes (Fig. 4 B). However, anti-CCR2–
treated mice also had fewer intestinal neutrophils. Given
that CCR2 is not expressed by neutrophils, it is likely that
this reduction is secondary to diminished accumulation
of inflammatory monocytes, which are known to release
cytokines and chemokines that recruit neutrophils, such as
IL-1 (Rogers et al., 1994). To definitively assess the contribution of neutrophils to anti-CD40–induced colitis, we
selectively depleted neutrophils using an anti-Ly6G antibody. We found that neutrophil depletion did not attenuate
disease severity (Fig. 4 C). Our results indicate that inflammatory monocytes have a predominant pathogenic role
over neutrophils in anti-CD40–induced colitis and, therefore, ILC3s may promote colitis primarily by inducing
accumulation and activation of inflammatory monocytes
in the intestine.

1874
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Figure 3. Adoptively transferred ILC3s cause severe colitis in
NSG mice. 2 × 104 small intestinal ILC3s (CD45+Lin–Thy1+CD127+
cells) sort-purified from Rag1/ mice were intravenously injected
into NSG mice. (A) After 8 wk, mice were treated with anti-CD40, and
body weights were measured daily, from 0 to 7 d p.i. Data represent
two independent experiments with four mice/group. (B) Cells were
purified from the small intestinal lamina propria. ILC3s were identified
as CD45+LinThy1+RORt+ cells. Data represent three independent
experiments with two mice/group. (C) Ly6G+ neutrophils and Ly6G–
Ly6Chi inflammatory monocytes were distinguished within the population of live CD45+CD19–CD11b+ cells and (D) absolute numbers
quantified. Data are representative of three experiments with two
mice/group (C) or two independent experiments with five mice/group (D).
*, P < 0.05, Student’s t test. Bars represent mean ± SEM.

Neutralization of GM-CSF and IL-22 ameliorates
anti-CD40–induced colitis
We asked how ILC3s drive accumulation of Ly6C+ monocytes in the intestine and promote subsequent inflammation.
We and others have previously shown that ILC3s produce
GM-CSF (Cella et al., 2009; Mortha et al., 2014). Moreover,
it has been shown that GM-CSF drives extramedullary
expansion of inflammatory monocytes from granulocytemonocyte progenitors (GMPs) during inflammation (Griseri
et al., 2012). Based on these data and the finding that
GM-CSF was substantially reduced in ART mice compared
with Tcrbd/ controls (Fig. 1 D) after anti-CD40 injection,
we hypothesized that ILC3s drive colitis by producing GMCSF required for the expansion, survival, and function of
inflammatory monocytes. Consistent with this hypothesis,
we observed that anti-CD40 induced robust production of
GM-CSF by ILC3s, particularly by NKp46+ILC3s (Fig. 5 A).
We next assessed disease severity and accumulation of Ly6C+
monocytes during anti-CD40–induced colitis in Tcrbd/
mice treated with an anti–GM-CSF–neutralizing antibody.
Tcrbd/ mice receiving anti–GM-CSF recovered as quickly
as ART mice, whereas Tcrbd/ treated with a control antibody showed persistent weight loss (Fig. 5 B). Recovery
was paralleled by a significant reduction of intestinal Ly6C+
monocytes (Fig. 5, C and D).
Because all ILC3s produce IL-22, which can promote
inflammation by stimulating epithelial cell secretion of
chemoattractants for myeloid cells (Ouyang et al., 2008),
we asked whether IL-22 has a pathogenic role in this
model. Neutralization of IL-22 with a specific antibody reduced the severity of anti-CD40–induced colitis (Fig. 5 B)
and the accumulation of Ly6C+ monocytes (Fig. 5 C) to a
degree similar though significantly less than anti-GMCSF (Fig. 5 D). We conclude that ILC3s promote colitis
through secretion of GM-CSF and IL-22. GM-CSF directly promotes the accumulation of inflammatory myeloid
cells; IL-22 likely acts indirectly, by stimulating epithelial
cells to secrete myeloid cell chemoattractants (Ouyang
et al., 2008).
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Figure 4. Impact of inflammatory monocytes and neutrophils depletion on anti-CD40–induced colitis. Tcrbd/ mice were treated with (A)
anti-GR1 (RB6-8C5) or control IgG at days 1, 1, 3, and 5; (B) anti-CCR2 (MC-21) or control IgG at days 4, 1, 2, 3, and 4; (C) anti-Ly6G (1A8), or control IgG at days 1, 1, 3, and 5. Anti-CD40 was injected at day 0. (A–C) Numbers of intestinal neutrophils and inflammatory monocytes among 106 total
leukocytes present in the colon are indicated for each antibody treatment to indicate the efficacy of depletion. *, P < 0.05; ***, P < 0.001, Student’s t test.
Data are representative of three experiments (A and C) or two experiments (B) with four to five mice/group. Bars represent mean ± SEM.

Lack of NKp46+ILC3s is sufficient to protect mice from
anti-CD40–induced colitis
To determine whether NKp46+ and LTi-like ILC3s have
unique or redundant roles in the pathogenesis of intestinal
inflammation induced by anti-CD40, we examined the antiCD40 model in RNT mice. After anti-CD40 injection, remarkably, RNT mice phenocopied the ART mice: they lost
less weight and recovered earlier than Tcrbd/ mice (Fig. 6 A).
Moreover, RNT mice exhibited less colonic shortening than
Tcrbd/ mice (Fig. 6 B). Recruitment of neutrophils and
inflammatory monocytes was also reduced (Fig. 6 C). The
JEM Vol. 212, No. 11

content of IL-22, S100A8, NOS2, IL-17F, IFN-, TNF,
IL-1, IL-6, and GM-CSF in the small intestine of RNT
mice was markedly lower than in Tcrbd/ mice (Fig. 6 D).
Consistent with the presence of fewer NKp46+ILC3s in the
colon than small intestine and less efficient depletion in this
organ (Fig. S1 D), reduction of NKp46+ILC3s in RNT mice
had less impact on many inflammatory mediators, which
remained elevated (Fig. 6 E). However, GM-CSF was significantly reduced in colon, as were indicators of epithelia
cell inflammation, such as S100A8 and NOS2. To test the
differential ability of NKp46+ILC3s and LTi-like ILC3s to
1875
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specifically induce colitis, we isolated both subsets and independently transferred them into NSG mice, as we had previously done with bulk ILC3s. NSG mice reconstituted with
NKp46+ILC3s lost more weight than mice reconstituted
with NKp46– ILC3s (Fig. 6 F). Thus, lack of NKp46+ILC3s is
necessary and sufficient to protect mice from anti-CD40–
induced colitis, suggesting a crucial role of NKp46+ILC3s
in intestinal inflammation due to inappropriate secretion of
GM-CSF and, in part, IL-22 and subsequent activation and
recruitment of inflammatory monocytes.
Given the robust and unregulated inflammation in the
anti-CD40 model, it possible that the physiological role of
ILC3s as a mucosal sentinels via their production of IL-22
and GM-CSF become hijacked and improperly proinflammatory. Indeed, we noticed that ART and NRT mice injected with anti-CD40 have larger and heavier spleens
than Tcrbd/ mice (unpublished data). We also detected
bacterial growth in the spleens of ART and RNT mice but
not Tcrbd/ mice (unpublished data), which corresponded
to higher serum levels of TNF and IFN- (unpublished
data). These results suggest that although ILC3s have deleterious local effects during inappropriate intestinal inflammation, they may be important for maintaining intestinal barrier
1876

function and preventing bacterial translocation, at least in
T cell–deficient mice.
Partial redundancy of ILC3s and T cells in C. rodentium
infection
Many studies in mice have demonstrated that ILC3s mediate
protection from C. rodentium infection, mainly through the
production of IL-22. However, most of these studies have examined the impact of ILC3s in immunodeficient mice, like
Rag-deficient mice, which lack important adaptive sources of
IL-22, such as TH17, TH22, and  T cells (Sutton et al.,
2009). Moreover, the role of ILC3s has been frequently assessed by anti-Thy1–mediated depletion, a method that depletes all ILCs and NK cells. To assess the specific contributions
of ILC3s, particularly NKp46+ILC3s, and T cells during
C. rodentium infection, we compared WT, AR, NR, ART, RNT,
and Tcrbd/ mice. As expected, AR infected with C. rodentium lost weight and 50% died by day 35 p.i., whereas WT
mice were resistant to infection (Fig. 7 A). Because AR mice
lack ILC3s but may also have defects in TH17 and TH22 cells,
we attributed this susceptibility to concurrent deficits in
ILC3s and T cells. However, RN mice were resistant to infection, just like WT control mice, suggesting that NKp46+ILC3s
NKp46+ ILC3s in intestinal inflammation | Song et al.
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Figure 5. Impact of GM-CSF and IL-22 neutralization on anti-CD40–induced colitis. (A) Representative plots show intracellular content of
GM-CSF in LTi-like ILC3s (NKp46–) and NKp46+ILC3s isolated from the small intestines of Tcrbd/ and ART mice, 6 d after treatment with anti-CD40.
Cells were surface stained to identify NKp46+ and NKp46 ILC3s; GM-CSF and TNF content were determined after 4-h culture in the presence of monensin. Data represent three independent experiments with two mice/group. (B and C) Tcrbd/ mice were treated with anti–GM-CSF (MP1-22E9), anti–IL-22
(8E11), or control IgG at days 0, 2, 4, and 6. ART mice received no neutralizing antibodies. Anti-CD40 was injected into all mice at day 0. (B) Mice were
weighed daily, from 0 to 7 d p.i. Data represent three independent experiments with five mice/group. (C) Representative plots of intestinal inflammatory
monocytes present in the colon of antibody-treated mice. (D) Quantification of inflammatory monocytes as represented in (C). C and D represent three
independent experiments with two mice/group. *, P < 0.05; **, P < 0.01, Student’s t test. Bars represent mean ± SEM.
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Figure 6. Lack of NKp46+ ILC3s curbs inflammation during anti-CD40–induced colitis. RNT and Tcrbd/ mice were injected with anti-CD40.
(A) Mice were weighed daily after antibody administration. Data represent five independent experiments with five mice/group. (B) Colons from Tcrbd/
and RNT mice were isolated 7 d after anti-CD40 injection and total lengths measured. Data represent three independent experiments with four to five
mice/group. (C) Cells were purified from the small intestine LP. Ly6G+ neutrophils and Ly6G–Ly6Chi inflammatory monocytes were distinguished within the
population of live CD45+CD19–CD11b+ cells. Representative plots (left) and total neutrophil and monocyte numbers among 106 total leukocytes (right) are
indicated. Data represent three independent experiments with two mice/group. Small intestines (D) and colons (E) were collected at day 7 after anti-CD40
injection, RNA was extracted and cytokine content was measured by quantitative RT-PCR. Y axis demonstrates relative transcript abundance and x axis
shows day p.i. Data in D and E represent three independent experiments with five mice/group (F) NKp46+ ILC3 (CD45+Thy1+CD127+NK1.1–KLRG1–NKp46+)
and LTi-like ILC3 (CD45+Thy1+CD127+ NK1.1–KLRG1–NKp46–) subsets from small intestine lamina propria were sort purified from Rag1/ mice and intravenously injected into NSG mice. After 8 wk, mice were treated with anti-CD40, and body weights were measured daily, from 0 to 7 d p.i. Data represent
two independent experiments with five mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test. Bars represent mean ± SEM.

are unnecessary to control C. rodentium in the presence of
T cells (Fig. 7 B). To tease apart the contributions of ILC3s
and T cells, we further analyzed Tcrbd/, ART, and RNT
mice. Tcrbd/ mice were highly susceptible to infection, with
marked weight loss and 100% mortality at ~ day 40 p.i.; in
comparison, ART mice had accelerated body weight loss and
JEM Vol. 212, No. 11

100% mortality by day 20 (Fig. 7 C). Thus, both T cells and
ILC3s contribute to antibacterial defense. Conversely, RNT
mice and Tcrbd/ controls were equally susceptible to
C. rodentium infection (Fig. 7 D); body weight loss and mortality
post-infection overlapped in RNT and Tcrbd/ mice. Thus,
NKp46+ILC3s alone are not required to resist C. rodentium
1877
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DISCUSSION
NKp46+ and LTi-like ILC3s are two distinct subsets of
ILC3s that have been shown to diverge in their development. Although both subsets depend on RORt and AHR,
NKp46+ILC3s also require Notch and T-bet, whereas LTi-like
ILC3s do not. Because NKp46+ILC3s express both RORt
and T-bet, they have functional plasticity such that, under
certain conditions, they down-regulate RORt, up-regulate
T-bet, and produce IFN- (Klose et al., 2013; Rankin et al.,
2013b). Despite the knowledge that ILC3 subsets developmentally and transcriptionally diverge, it remains unclear the
extent to which they are functionally distinct. Our study advances the functional characterization of NKp46+ILC3s by
demonstrating their capacity to secrete GM-CSF and promote the accumulation and activation of inflammatory monocytes. This functional property of NKp46+ILC3s is evident
in the anti-CD40 model of colitis, as demonstrated by the
marked intracellular content of GM-CSF in NKp46+ILC3s,
as well as the reduction of disease severity after deletion of
NKp46+ILC3s in RNT mice or neutralization of GM-CSF
in Tcrbd/ mice. Thus, NKp46+ILC3s are necessary and sufficient to induce intestinal pathology when inappropriately
Figure 7. Contribution of ILC3s to defense against C. rodentium
infection. (A–D) C. rodentium (2 × 109) was administrated by oral gavage
to 8–12-wk-old B6 (A and B), AR (A), RN (B), Tcrbd/ (C and D), ART (C),
and RNT (D) mice. Body weight and survival were monitored from 0 to
40 d p.i. (A–D) Data represent at least three independent experiments with
5–10 mice/group. (E) RNA was isolated from colons of Tcrbd/ and ART
mice at day 7 after injection; Il22, Il17a, Il17f, Ifng, and Csf2 were measured by RT-PCR. All gene expression values were normalized to Gapdh.
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Data represent three independent experiments with five mice/group.
(F) Neutrophil depletion in Tcrbd/ mice accelerates lethality to C. rodentium infection. Mice were infected and neutrophil depletion performed
every 3 d by administration of 100 µg of anti-Ly6G (1A8) antibody.
(E and F) Data are representative of three independent experiments with
five mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001,
Student’s t test.
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challenge even in the absence of T cells, presumably because
LTi-like ILC3s provide sufficient protection.
We more broadly investigated the mechanisms by which
ILC3s contribute to C. rodentium susceptibility in ART mice.
ART mice had markedly less IL-22 in the colon at day 7 p.i.
than did Tcrbd/ mice. Levels of IL-17A/F, IFN-, and
GM-CSF were also reduced in the colons of ART mice
(Fig. 7 E). Furthermore, significantly fewer CD11b+Ly6G+
neutrophils accumulated in the colons of ART mice than
in the colons of Tcrbd/ mice after C. rodentium infection
(unpublished data). Because neutrophils are known to be
important mediators of C. rodentium clearance (Wang et al.,
2010; Kamada et al., 2015), we focused on the potential
impact of limited neutrophil accumulation in ART mice
on the outcome of infection. Depletion of neutrophils in
Tcrbd/ mice using anti-Ly6G (1A8) during C. rodentium
infection caused increased disease severity, recapitulating the
phenotype seen in ART mice (Fig. 7 F). Thus, ILC3s contribute to protection against C. rodentium infection in Tcrbd/
by promoting neutrophil accumulation. We conclude that
functionally competent ILC3s are essential to resist C. rodentium
when T cell responses are also compromised. When T cells
are present, ILC3s have limited impact and NKp46+ILC3s
are dispensable.
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ILC1s. Thus, our study highlights that a spectrum of ILC
subsets contribute to anti-CD40 colitis, perhaps through conversion, as well as independent functions. Moreover, both of
the aforementioned studies indicate that colitis is induced by
IFN-–producing cells (Buonocore et al., 2010;Vonarbourg
et al., 2010), which may be an additional mechanism beside
the pathogenic role of ILC3-derived GM-CSF that we
identified here.
Remarkably, neutralization of IL-22 also eased disease severity in this colitis model. Thus, although IL-22 is generally
thought to have a protective function on the intestinal mucosa, our results indicate that in some circumstances IL-22
promotes inflammation. IL-22 was recently shown to induce
transcription of IL-18 in epithelial cells (Muñoz et al., 2015).
Our own data suggest that IL-22 may also induce transcription of IL-33 (unpublished data). Moreover, IL-22 stimulates
epithelial cells to produce chemokines that attract myeloid
cells (Rutz et al., 2014). Finally, IL-22 activates STAT3, a
transcription factor induced by many inflammatory cytokines
that has been implicated in chronic inflammation and cancer
(Ghoreschi et al., 2011). Thus, IL-22 may cause inflammation, perhaps when it is secreted in excess and/or acts in
concert with other stimuli that activate IL-18, IL-33, and
myeloid cells. The pathogenic function of IL-22 in the antiCD40 model is also consistent with results from a different
model of colitis induced by adoptive transfer of T reg celldepleted CD45RBlo memory T cells into Rag-deficient mice
(Kamanaka et al., 2011). Elucidating how this dual functionality of IL-22 is achieved may lead to a better understanding
of inflammatory bowel diseases.
In contrast to their pathogenic role in anti-CD40 colitis,
neither NKp46+ILC3s nor ILC3s in general had an impact
on the course of DSS-induced colitis (unpublished data),
whether it was induced in immunocompetent or T cell–
depleted mice. DSS treatment damages the intestinal epithelium, thereby exposing immune cells of the lamina propria to
the intestinal microbiota and its products. It is possible that
DSS-induced colitis is relatively independent of GM-CSF–
mediated activation of inflammatory monocytes and that
other pathways, such as activation of local macrophages or
other cells of the innate immune system by intestinal microbiota,
are predominant in this model.
Given that many studies have focused on the role of
ILCs in immunocompromised mice, particularly Rag-deficient
mice, it remains largely unclear the extent to which many
ILCs have unique functions apart from T cells and B cells.
Our study parses the role of ILC3s and T cells, both of which
provide important sources of IL-22 for antibacterial defense,
in host defense against C. rodentium infection in the presence
of B cells. We found that ILC3s have a marked impact on
host defense when T cells are absent, consistent with previous studies (Sonnenberg et al., 2011; Basu et al., 2012).
However, whereas ART mice were more susceptible to infection than Tcrbd/ mice, RNT mice and Tcrbd/ mice
were equally susceptible, suggesting that LTi-like ILC3s
are sufficient to control C. rodentium infection, whereas the
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activated. A previous study showed that IL-1 stimulates
ILC3s to produce GM-CSF (Mortha et al., 2014). However,
incubation of NKp46+ILC3s with IL-1 was not sufficient to
elicit GM-CSF in vitro. Similarly, human CD56+NKp44+ILC3s
did not secrete GM-CSF in response to IL-1 (unpublished
data). Given these data, we postulate that induction of GM-CSF
secretion requires multiple cytokines, including those induced
by anti-CD40 stimulation of myeloid cells, rather than a single cytokine. Engagement of one or more cell surface receptors on NKp46+ILC3s, including NKp46, may also contribute
to GM-CSF secretion.
GM-CSF and inflammatory monocytes have been identified as the culprits mediating tissue damage in a model
of experimental autoimmune encephalomyelitis (Becher and
Segal, 2011). Moreover, GM-CSF was shown to promote
disease in a T cell transfer model of colitis by inducing excessive accumulation of granulocyte-monocyte progenitors
(GMP) and consequent extramedullary production of neutrophils and inflammatory monocytes (Griseri et al., 2012).
Inflammatory monocytes, in turn, promote tissue damage
and dysbiosis (Zigmond et al., 2012; Seo et al., 2015). Our
study shows, for the first time, that the pathogenesis of antiCD40–induced innate immune colitis is also GM-CSF dependent. GM-CSF acts primarily by recruiting and activating
inflammatory monocytes. We used CCR2 depletion and
GM-CSF neutralization experiments to this end. A previous
study proposed that ILC3s cause intestinal damage in the
anti-CD40 model of colitis by recruiting neutrophils (Eken
et al., 2014). We also observed that ILC3s induce neutrophil
accumulation by stimulating the release of neutrophil chemoattractants by monocytes and epithelial cells. However,
neutrophil depletion had no impact on colitis, which suggests
that inflammatory monocytes dominate the pathogenic process. Because inflammatory monocytes provide an important
source of IL-23 and IL-1 that stimulate ILC3s (Cella et al.,
2009; Longman et al., 2014), recruitment of inflammatory
monocytes likely generates a positive feedback loop that amplifies inflammation. Notably, this inflammation may reflect
the physiological function of ILC3 to maintain epithelial homeostasis and support wound healing, which is hijacked in
immunocompromised mice by a strong activating inflammatory stimulus such as CD40 cross-linking.
Our study genetically defines NKp46+ILC3s as a colitogenic cell subset in the anti-CD40–induced model. A previous study by Buonocore et al. (2010) showed that colitis is
induced by a colonic NKp46 Thy1+ Sca1high subset that
is probably unrelated to the ILC subsets that we examined, as
in our experiments colitogenic cells are primarily NKp46+
RORt+ ILC3s. In another study, Vonarbourg et al. (2010)
indicated that NKp46+ RORt cells can induce colitis after
adoptive transfer. These cells include RORt+ cells that have
converted into RORt cells (ex-RORt cells), but may
also include ILC1s and perhaps NK cells. By deleting NKp46+
Rort+ cells in RNT mice, we also eliminate ex-RORt
NKp46+ cells (which represent 30–50% of NKp46+NK1.1+
cells in our colony; unpublished data) but not NK cells or
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MATERIALS AND METHODS
Mice. Ahrf/f (Walisser et al., 2005), Rorc(t)-cre (Eberl and Littman, 2004),
Rorc(t)f/f (Eberl and Littman, 2004), NKp46-cre (Narni-Mancinelli et al.,
2011), and Rosa26-stop-YFP reporter (Rosa26stop-YFP/+; Srinivas et al., 2001)
mice were kept in specific pathogen–free conditions at the animal facility of
Washington University. All animal studies were approved by the Washington University Animal Studies Committee.
Anti-CD40–induced colitis. 6–10-week-old age- and gender-matched mice
were injected i.p. with 100 µg of anti-CD40 antibody. Body weight was measured daily, and mice were dissected at day 4 or day 7 after injection. Colons
were removed, cleaned, and processed, as previously described (Lee et al., 2012).
C. rodentium infection. 8–12-week-old age and gender-matched mice
were orally administrated 2 × 109 C. rodentium, strain DBS100 (ATCC), as
previously described (Cella et al., 2009). Body weight and mortality were
measured until day 40. In some cases, mice were sacrificed at day 7 and colons were removed for RNA analysis and flow cytometry.
Flow cytometry. Cells were isolated from the colon and small intestine
lamina propria by Percoll-gradient method and surface stained with the indicated antibodies. Conjugated antibodies for staining were purchased from
eBioscience, BD, and BioLegend. For intracellular cytokine staining, cells
were cultured with complete RPMI medium containing monensin for 4–6 h.
Cells were then fixed and stained according to manufacturer’s instructions,
using an intracellular cytokine staining kit (eBioscience).
Cytokine measurements. Purified colon lamina propria cells were counted,
and 106 cells were cultured in complete RPMI for 4–6 h or overnight. Cytokines were measured by bead array with the Mouse Inflammation or Mouse
Th1/Th2/Th17 CBA kit (BD).
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Histology. Colons were washed with PBS, and fixed in 10% phosphatebuffered formalin overnight and then transferred to 70% ethanol. Fixed tissues were then paraffin-embedded, sectioned, and stained with hematoxylin
and eosin (H&E). Severity of inflammation was scored blinded, as previously
described. Two intestinal pieces from the same mouse were scored and the
cumulative score is plotted (Satpathy et al., 2013).
Depletions. Tcrbd/ mice were injected i.p. with either 20 µg of anti-CCR2
(MC-21) daily, 200 µg of anti-Ly6G (1A8) every other day, 100 µg of anti-GR1
(RB6-8C5) every other day, or control IgG. Anti-CD40 was injected at day 0.
Anti–GM-CSF (MPI-22E9) and anti–IL-22 (8E11) used for neutralization
experiments were obtained from Bioxcell and Genentech, respectively.
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Figure S1. Gating strategy for ILC3 subsets in B6, AR, RN, ART, RNT, and Tcrbdⴚ/ⴚ mice. (A) Representative plots of ILC3 subsets in the small intestinal, cecal, and
colonic LP of B6 mice. Live CD45+Lin2Rorgt+Thy1+ cells were gated and analyzed for expression of CCR6 and NKp46. (B) Total numbers of LTi-like ILC3s (CCR6+NKp46ⴚ and
CCR6ⴚNKp46ⴚ) and NKp46+ ILC3s, among 106 total leukocytes, found in the small intestinal, cecal, and colonic LP. (C) Representative plots of ILC3 subsets in the small intestinal,
cecal, and colonic LP of Tcrbd⫺/⫺ mice. (D) Numbers of LTi-like ILC3s (CCR6ⴚNKp46ⴚ and CCR6+NKp46ⴚ) and NKp46+ ILC3s (CCR6ⴚNKp46+) found in the small intestinal, cecal,
and colonic LP of Tcrbd⫺/⫺, ART, and RNT mice. Data are representative of four mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test. Bars represent mean ± SEM.
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